HIV Databases HIV Databases home HIV Databases home
HIV Sequence Database



Download: ENTIRE SEQUENCE SEQUENCE FRAGMENT start end
Format:  
View NCBI entry		Download GenBank file		Graphics View		Download GFF3 File

LOCUS	    HQ993629		    1380 bp    DNA     linear	VRL 07-NOV-2011
DEFINITION  UNVERIFIED: HIV-1 isolate CP076301591 from Kenya genomic sequence
ACCESSION   HQ993629
VERSION     HQ993629.1 GI:355337478
KEYWORDS    UNVERIFIED.
SOURCE	    Human immunodeficiency virus 1 (HIV-1)
  ORGANISM  Human immunodeficiency virus 1 Viruses; Retro-transcribing viruses;
	    Retroviridae; Orthoretrovirinae; Lentivirus; Primate lentivirus
	    group
REFERENCE   1 (bases 1 to 1380)
            Show all sequences for reference 1
  AUTHORS   Hamers,R.L., Wallis,C.L., Kityo,C., Siwale,M., Mandaliya,K.,
	    Conradie,F., Botes,M.E., Wellington,M., Osibogun,A., Sigaloff,K.C.,
	    Nankya,I., Schuurman,R., Wit,F.W., Stevens,W.S., Van Vugt,M. and de
	    Wit,T.F.
  CONSRTM   for PharmAccess African Studies to Evaluate Resistance (PASER)
  TITLE     HIV-1 drug resistance in antiretroviral-naive individuals in
	    sub-Saharan Africa after rollout of antiretroviral therapy: a
	    multicentre observational study
  JOURNAL   Lancet Infect Dis 11 (10), 750-759 (2011)
  PUBMED    21802367
REFERENCE   2 (bases 1 to 1380)
            Show all sequences for reference 2
  AUTHORS   Hamers,R.L., Wallis,C., Kityo,C., Siwale,M., Conradie,F.,
	    Mandaliya,K., Botes,M., Wellington,M., Osibigun,A.,
	    Sigaloff,K.C.E., Schuurman,R., Stevens,W.S., Van Vugt,M. and Rinke
	    de Wit,T.F.
  CONSRTM   PharmAccess African Studies to Evaluate Resistance (PASER)
  TITLE     Direct Submission
  JOURNAL   Submitted (14-JAN-2011) Amsterdam Institute for Global Health and
	    Development, PharmAccess Foundation, Pietersbergweg 17, Amsterdam,
	    NH 1105BM, The Netherlands
REFERENCE   3
            Show all sequences for reference 3
  AUTHORS   Hamers,R.L., Schuurman,R., Sigaloff,K.C.E., Wallis,C.L., Kityo,C.,
	    Siwale,M., Mandaliya,K., Ive,P., Botes,M.E., Wellington,M.,
	    Osibogun,A., Wit,F.W., Van Vugt,M., Stevens,W.S. and De Wit,T.F.R.
  CONSRTM   PASER
  TITLE     Effect of pretreatment HIV-1 drug resistance on immunological,
	    virological, and drug-resistance outcomes of first-line
	    antiretroviral treatment in sub-Saharan Africa: a multicentre
	    cohort study.
  JOURNAL   Lancet. Infect. Dis.. 12(4); 307-17 (2012)
  PUBMED    22036233
COMMENT     GenBank staff is unable to verify sequence and/or annotation
	    provided by the submitter.
FEATURES             Location/Qualifiers
     source	     1..1380
		     /organism="Human immunodeficiency virus 1"
		     /proviral="Human immunodeficiency virus 1"
		     /mol_type="genomic DNA"
		     /isolate="CP076301591"
		     /host="Homo sapiens"
		     /db_xref="taxon:11676"
		     /country="Kenya"
		     /note="collection date range 2007-2009"
BASE COUNT	520 a	 236 c	  297 g    307 t     20 other
ORIGIN
       1 gactggaacc aacagcccca ccagcagaga tctgtgggat gagggaagag gcagcctccc 
      61 ctccgaagca gggggaacag actccacctt taatttccct caaatcactc tttggcagcg 
     121 acccgttgtc acaataaaaa tagggggaca gctgaaagaa gctctattag atacaggagc 
     181 agatgataca gtatttgaag acatagattt rccaggaaaa tggaaaccaa gaatgatagg 
     241 gggaattgga ggttttatca aagtaaaaca gtatgatcac atacctatag aaatttgtgg 
     301 aaaaaaggct ayaggtacag tattagtagg acctacacct gtcaacatag ttggaagraa 
     361 tatgttgacc cagattggat gcactttaaa tttcccaatt agtcctattg agactgtacc 
     421 agtaaaatta aagccaggaa tggatggccc aaaagttaaa caatggccat tgacagaaga 
     481 aaaaataaaa gcattaacag aaatttgttt agaaatggaa aaggagggaa arattacaaa 
     541 aattgggcct gaaaatccat acaacactcc aatatttgcc ataaagaaga aagacagtac 
     601 taartggaga aaattagtag atttcaggga actcaataaa agaactcaag acttttggga 
     661 agttcaatta gggataccac acccagcagg gttaaaaaag aaaaaatcag tgacagtact 
     721 rgatgtgggg gatgcrtatt tttcagttcc tttagataaa gatttcagga aatatactgc 
     781 attcaccata cctagtrtaa acaatgarac accaggmrtt agatatcagt ataatgtgct 
     841 tccacaggga tggaaaggat caccagcaat attycaaagt agcatgacaa aaatcttaga 
     901 gccctttaga aaacaaaatc cagaaatagt tatctatcaa tacatggatg atttgtatgt 
     961 aggatctgac ttagaaatag ggcaacatag agcaaaaata gaggagttaa gagarcatct 
    1021 attgargtgg ggattyacca cmccagacaa aaarcatcaa aaagaacctc catttctgtg 
    1081 gatggggtat gaactccatc ctgacaaatg gacrgtacag cctatacagc taccagaaaa 
    1141 rgatagctgg actgtcaatg atatacagaa gttagtggga aagttaaact gggcaagtca 
    1201 gatttaccca gggattcaag tgaagcagct gtgtagactc cttaggggag ccaargcctt 
    1261 aacagacata gtaccactga ctgaagaagc agaattagaa ttggcagaga acagggagat 
    1321 tctaagagaa ccagtacatg gagtatatta tgacccatca aaagacttaa tagcagaact 
//
last modified: Tue May 31 10:56 2022


Questions or comments? Contact us at seq-info@lanl.gov.

 
Operated by Triad National Security, LLC for the U.S. Department of Energy's National Nuclear Security Administration
© Copyright Triad National Security, LLC. All Rights Reserved | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health